Biodesix (BDSX)
(Real Time Quote from BATS)
$1.62 USD
+0.03 (1.89%)
Updated Aug 8, 2024 12:04 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Biodesix, Inc. (BDSX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$3.08 | $3.50 | $2.80 | 93.71% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Biodesix, Inc. comes to $3.08. The forecasts range from a low of $2.80 to a high of $3.50. The average price target represents an increase of 93.71% from the last closing price of $1.59.
Analyst Price Targets (4 )
Broker Rating
Biodesix, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on four recommendations.
Of the five recommendations deriving the current ABR, five are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/26/2024 | Craig-Hallum | William B Bonello | Not Available | Strong Buy |
5/20/2024 | William Blair | Andrew F Brackmann | Strong Buy | Strong Buy |
5/3/2024 | Lake Street Capital Markets | Thomas Flaten | Not Available | Strong Buy |
3/4/2024 | Canaccord Genuity | Kyle Mikson | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 5 |
Average Target Price | $3.08 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 151 of 253 |
Current Quarter EPS Est: | -0.07 |